Amylyx Pharmaceuticals (AMLX) Receivables (2022 - 2025)
Amylyx Pharmaceuticals (AMLX) posted quarterly Receivables of $188000.0 for Q4 2025, down 65.63% year-over-year from $547000.0 in Q4 2024, and down 18.97% quarter-over-quarter from $232000.0 in Q3 2025.
Amylyx Pharmaceuticals (AMLX) Receivables (2022 - 2025) Analysis & Trends
Amylyx Pharmaceuticals' Receivables history runs 4 years deep, the most recent figure standing at $188000.0 for Q4 2025.
- In Q4 2025, Receivables fell 65.63% year-over-year to $188000.0; the TTM figure through Dec 2025 stood at $188000.0 (down 65.63% YoY), while the FY2025 annual figure was $188000.0, down 65.63% from the prior year.
- Receivables for Q4 2025 stood at $188000.0, down from $232000.0 in the prior quarter.
- The five-year high for Receivables was $40.6 million in Q4 2023, with the low at $137000.0 in Q3 2022.
- The 4-year median for Receivables is $3.0 million (2024), against an average of $11.9 million.
- The sharpest annual moves came in 2023 and 2024: Receivables soared 21398.54% in 2023, then sank 98.65% in 2024.
- Amylyx Pharmaceuticals' Receivables stood at $15.8 million in 2022, then surged by 156.55% to $40.6 million in 2023, then tumbled by 98.65% to $547000.0 in 2024, then sank by 65.63% to $188000.0 in 2025.
- Business Quant data shows AMLX's Receivables at $188000.0 in Q4 2025, $232000.0 in Q3 2025, and $203000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.71 Bn | 42.75 Bn | - | 3.07 Bn |
| 2 | Teva Pharmaceutical Industries | 43.11 Bn | 39.45 Bn | 2.15 Bn | 3.49 Bn |
| 3 | Zoetis | 31.62 Bn | 29.94 Bn | 1.05 Bn | 1.57 Bn |
| 4 | Takeda Pharmaceutical | 28.72 Bn | 22.92 Bn | 5.10 Bn | 5.84 Bn |
| 5 | United Therapeutics | 22.33 Bn | 19.67 Bn | 683.80 Mn | 310.30 Mn |
| 6 | Viatris | 18.83 Bn | 17.95 Bn | 1.46 Bn | 3.67 Bn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 887.00 Mn |
| 8 | Elanco Animal Health | 12.10 Bn | 11.57 Bn | 798.00 Mn | 1.15 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 1.08 Bn |
| 10 | Amylyx Pharmaceuticals | 4.28 Bn | 4.28 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 188,000.00 |
| Sep 30, 2025 | 232,000.00 |
| Jun 30, 2025 | 203,000.00 |
| Mar 31, 2025 | 400,000.00 |
| Dec 31, 2024 | 547,000.00 |
| Sep 30, 2024 | 1.83 Mn |
| Jun 30, 2024 | 4.19 Mn |
| Mar 31, 2024 | 20.65 Mn |
| Dec 31, 2023 | 40.55 Mn |
| Sep 30, 2023 | 29.45 Mn |
| Jun 30, 2023 | 34.27 Mn |
| Mar 31, 2023 | 17.86 Mn |
| Dec 31, 2022 | 15.81 Mn |
| Sep 30, 2022 | 137,000.00 |